Nutrien (NYSE:NTR – Get Free Report) released its quarterly earnings data on Wednesday. The company reported $0.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.74 by ($0.13), Briefing.com reports. Nutrien had a net margin of 8.44% and a return on equity of 8.88%. The firm’s quarterly revenue was up .9% compared to the same quarter last year. During the same period last year, the company posted $0.97 earnings per share.
Nutrien Trading Up 3.9%
NTR traded up $2.73 during trading on Wednesday, hitting $72.05. The company’s stock had a trading volume of 3,439,787 shares, compared to its average volume of 2,338,140. Nutrien has a twelve month low of $53.65 and a twelve month high of $85.36. The company has a quick ratio of 0.86, a current ratio of 1.39 and a debt-to-equity ratio of 0.36. The stock’s fifty day moving average price is $72.92 and its 200-day moving average price is $71.06. The firm has a market capitalization of $34.24 billion, a P/E ratio of 14.81, a PEG ratio of 0.77 and a beta of 0.67.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on NTR. Morgan Stanley reduced their target price on shares of Nutrien from $93.00 to $81.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. Mizuho decreased their price target on shares of Nutrien from $77.00 to $75.00 and set a “neutral” rating for the company in a research report on Tuesday, July 14th. Freedom Broker assumed coverage on shares of Nutrien in a research note on Tuesday, October 27th. They set a “hold” rating and a $78.00 price target for the company. Raymond James Financial cut their price target on shares of Nutrien from $90.00 to $83.00 and set an “outperform” rating on the stock in a report on Wednesday, October 28th. Finally, Jefferies Financial Group reiterated a “hold” rating and set a $71.00 price target on shares of Nutrien in a report on Monday, October 12th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Nutrien currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.24.
View Our Latest Stock Analysis on Nutrien
More Nutrien News
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Revenue was $6.06 billion, topping the $5.76 billion FactSet estimate, and Nutrien declared a quarterly dividend of US$0.55 per share. Revenue report Dividend announcement
- Neutral Sentiment: The company reported $1.31 billion in adjusted EBITDA and said it generated $4.85 billion in adjusted EBITDA over the first nine months of the year. Third-quarter results
- Negative Sentiment: Adjusted earnings per share were $0.61, below the $0.74 consensus and down from $0.97 a year earlier. Net profit fell 39% to about $290 million, despite the revenue beat. Earnings estimate comparison Profit decline report
- Negative Sentiment: Reports cited higher sulfur costs and a phosphate business downturn as factors behind the earnings shortfall. Nutrien also plans to close its Florida plant, adding to concerns about near-term operating pressures. Costs and Florida plant report
Nutrien Company Profile
Read More
- Five stocks we like better than Nutrien
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.
